Last reviewed · How we verify
AVX101
At a glance
| Generic name | AVX101 |
|---|---|
| Sponsor | AlphaVax, Inc. |
| Modality | Biologic |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Safety of an HIV Vaccine (AVX101) in HIV Uninfected Volunteers in the United States and South Africa (PHASE1)
- Safety of and Immune Response to an HIV-1 Subtype C Vaccine (AVX101) in HIV Uninfected Adults (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |